Bioinformatics Market to Reach USD 65.05 Billion by 2036 Amid Expanding Genomics Research and Growing Adoption of AI-Driven Computational Biology Platforms

NEWARK, Del., USA | JUNE 04, 2026 - According to the latest analysis by Future Market Insights, the global Bioinformatics Market is experiencing robust growth, driven by accelerating genomic data generation, increasing pharmaceutical investment in precision medicine, expanding applications of artificial intelligence in life sciences, and growing demand for computational tools capable of analyzing complex biological datasets. As sequencing technologies become more accessible and research institutions generate unprecedented volumes of biological data, bioinformatics platforms are emerging as critical infrastructure across pharmaceutical, biotechnology, agricultural, and clinical research environments.

Featured Snippet: Key Market Insights

• Market Size (2025): USD 18.70 Billion
• Market Value (2026): USD 20.94 Billion
• Forecast Value (2036): USD 65.05 Billion
• CAGR (2026-2036): 12.0%
• Incremental Opportunity: USD 44.11 Billion
• Top Growth Markets: India and China
• Key Drivers: Expanding genomic sequencing activities, AI-powered analytics adoption, pharmaceutical investment in precision medicine, growing computational biology applications
• Leading Product Segment: Bioinformatics Platforms
• Leading Application Segment: Genomics

👉 Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends: https://www.futuremarketinsights.com/reports/sample/rep-gb-22342

Market Overview: Genomic Data Explosion and AI Integration Accelerate Market Expansion

The bioinformatics market is projected to grow from USD 20.94 billion in 2026 to approximately USD 65.05 billion by 2036, registering a CAGR of 12.0% during the forecast period.

Market expansion is being fueled by declining sequencing costs, increasing adoption of next-generation sequencing (NGS), rising pharmaceutical demand for computational drug discovery, and growing utilization of cloud-based bioinformatics platforms. Organizations are increasingly relying on advanced computational tools to manage, analyze, and interpret large-scale biological datasets generated across genomics, proteomics, transcriptomics, and metabolomics research.

Key Market Drivers

1. Rapid Expansion of Genomic Data Generation

Growing sequencing activities continue to drive demand for advanced bioinformatics solutions.

Key growth contributors include:

• Increasing adoption of next-generation sequencing technologies
• Expansion of whole-genome and exome sequencing programs
• Rising population genomics initiatives
• Growing need for large-scale biological data management

The continuous increase in biological data generation is creating sustained demand for computational analysis platforms and cloud-based infrastructure.

2. Pharmaceutical Investment in Precision Medicine and Drug Discovery

Bioinformatics has become an essential component of modern pharmaceutical R&D.

This trend is supported by:

• Growing investment in biomarker discovery programs
• Expansion of precision medicine initiatives
• Increasing use of computational target identification
• Rising demand for AI-assisted drug development workflows

Pharmaceutical companies are leveraging bioinformatics tools to improve research efficiency and accelerate therapeutic development timelines.

3. Integration of Artificial Intelligence and Machine Learning

AI technologies are significantly enhancing bioinformatics capabilities.

Key developments include:

• Automated variant interpretation tools
• Predictive modeling for drug discovery
• Machine learning-enabled genomic analysis
• Advanced pattern recognition across multi-omics datasets

These innovations are expanding the analytical scope and commercial value of bioinformatics platforms.

👉 Speak to Analyst: Customize insights for your business strategy: https://www.futuremarketinsights.com/customization-available/rep-gb-22342

Segment Insights

Bioinformatics Platforms Lead Product Segment Demand

The Bioinformatics Platforms segment is expected to account for 37.4% of total product revenue in 2026 due to:

• Central role in genomic data management
• Growing adoption of cloud-based analysis environments
• Integration with sequencing workflows
• Strong demand from pharmaceutical and academic institutions

Bioinformatics platforms remain the foundation of computational biology operations across research and clinical settings.

Genomics Dominates Application Segment

The Genomics segment is projected to account for 32.9% of total application demand in 2026 owing to:

• Growth in whole-genome sequencing initiatives
• Increasing clinical genomics adoption
• Rising population-scale genomics studies
• Expanding personalized medicine programs

Genomics continues to represent the largest application area for bioinformatics solutions globally.

Medical Biotechnology Leads Sector Adoption

Medical biotechnology remains the largest sector due to:

• Strong pharmaceutical R&D investment
• Growing companion diagnostic development
• Increasing biomarker discovery initiatives
• Rising clinical genomics implementation

The sector continues to generate significant demand for computational biology tools and analytical services.

👉 Explore the Latest Healthcare Industry Analysis Now:
https://www.futuremarketinsights.com/industry-analysis/healthcare

Regional Insights

India

India is projected to register the fastest growth with a CAGR of 11.8% through 2036, driven by:

• Government investment in genomics initiatives
• Expanding biotechnology research ecosystem
• Growing computational biology talent pool
• Increasing adoption of precision medicine programs

India continues strengthening its position as a major bioinformatics growth market.

China

China is anticipated to expand at a CAGR of 11.2% owing to:

• Large-scale national genomics programs
• Expanding pharmaceutical research investments
• Rapid adoption of AI-powered analytics platforms
• Growing biotechnology infrastructure development

China remains one of the largest and fastest-growing bioinformatics markets globally.

South Korea

South Korea is expected to grow at a CAGR of 10.4% due to:

• Government-supported precision medicine initiatives
• Advanced digital infrastructure
• Growing pharmaceutical innovation activities
• Increased cloud-based platform adoption

The country continues investing heavily in computational healthcare technologies.

United States

The United States is projected to grow at a CAGR of 9.6% through 2036, supported by:

• Strong pharmaceutical R&D expenditure
• NIH-funded genomics research programs
• Widespread adoption of clinical genomics
• Advanced bioinformatics infrastructure

The U.S. remains a global leader in bioinformatics innovation and commercialization.

United Kingdom

The United Kingdom is expected to expand at a CAGR of 9.1% owing to:

• Genomics England initiatives
• Strong academic research capabilities
• Pharmaceutical industry adoption of computational biology
• Expanding precision medicine investments

The UK continues supporting growth through research-driven innovation.

Technology and Research Trends

The bioinformatics market is evolving through advancements in:

• AI-powered genomic analysis platforms
• Cloud-based bioinformatics deployment models
• Multi-omics data integration solutions
• Automated variant interpretation systems
• Advanced computational drug discovery tools

Manufacturers and software providers are increasingly focusing on improving analytical speed, scalability, and accessibility across research and clinical applications.

👉 Get Full Report Access for Detailed Analysis: https://www.futuremarketinsights.com/reports/bioinformatics-market

Challenges in the Market

Data Security and Regulatory Compliance Concerns

The market continues facing challenges from:

• Sensitive genomic data privacy requirements
• Increasing cybersecurity concerns
• Regulatory compliance complexities
• Cross-border data sharing restrictions

Organizations must balance innovation with stringent data governance requirements.

Shortage of Specialized Bioinformatics Expertise

Additional challenges include:

• Limited availability of skilled computational biologists
• Complex software implementation requirements
• High training and talent acquisition costs
• Integration challenges across research environments

Workforce development remains a critical priority across the industry.

Opportunities: AI-Powered Precision Medicine and Multi-Omics Analytics

The market is unlocking new opportunities through:

• Expansion of AI-driven drug discovery platforms
• Growth in precision medicine initiatives
• Increasing adoption of cloud computing infrastructure
• Integration of genomics, proteomics, and metabolomics datasets
• Rising investment in personalized healthcare technologies

Organizations capable of delivering scalable, interoperable, and AI-enhanced solutions are expected to strengthen their competitive positioning.

Competitive Landscape

The bioinformatics market remains highly competitive, with leading companies focusing on platform innovation, analytical capabilities, and global expansion.

Leading Companies

• Thermo Fisher Scientific Inc.
• Eurofins Scientific
• QIAGEN N.V.
• Agilent Technologies Inc.
• Illumina Inc.
• Waters Corporation
• NeoGenomics Laboratories

These organizations continue investing in platform development, cloud integration, and strategic partnerships to strengthen market leadership.

👉 Unlock high-growth opportunities with FMI's niche business market insights: https://www.futuremarketinsights.com/industry-analysis

Recent Developments

• Several leading bioinformatics providers expanded AI-powered analytics capabilities across genomic and multi-omics workflows during 2025.
• Pharmaceutical companies increased investments in computational biology platforms to accelerate biomarker discovery and drug target identification initiatives.
• Cloud-based bioinformatics solution providers introduced enhanced data management and collaborative research capabilities to support large-scale genomics programs.

Conclusion: Computational Biology to Become Core Infrastructure for Life Sciences Innovation

The bioinformatics market is rapidly evolving from a research support function into a foundational technology platform for genomics, precision medicine, pharmaceutical development, and biotechnology innovation. Expanding sequencing activities, increasing biological data complexity, growing AI adoption, and sustained investment in computational biology are expected to support strong market growth through 2036.

As genomics and multi-omics applications continue expanding globally, organizations capable of delivering scalable, secure, and intelligent bioinformatics solutions are expected to lead the next phase of growth in the global bioinformatics industry.

* FAQs

1. How large is the bioinformatics market in 2026?
The global bioinformatics market is estimated at USD 20.94 billion in 2026.

2. What will be the bioinformatics market size by 2036?
The market is projected to reach USD 65.05 billion by 2036.

3. What growth rate is expected for the bioinformatics market?
The market is expected to grow at a CAGR of 12.0% from 2026 to 2036.

4. Which product segment leads the market?
Bioinformatics Platforms are expected to lead with a 37.4% market share in 2026.

5. Which application segment dominates the market?
Genomics is expected to lead with a 32.9% share of the application segment in 2026.

* Have a Look at Related Research Reports on the Healthcare Domain

· Drug Discovery Informatics Market - https://www.futuremarketinsights.com/reports/drug-discovery-informatics-market

· Biomaterial Market - https://www.futuremarketinsights.com/reports/biomaterials-market

· Bipolar Disorder Drugs and Treatment Market - https://www.futuremarketinsights.com/reports/bipolar-disorder-drugs-and-treatment-market

· Cardiac Biomarker Diagnostic Test Kits Market - https://www.futuremarketinsights.com/reports/cardiac-bio-marker-diagnostic-test-market

· Remicade Biosimilar Market - https://www.futuremarketinsights.com/reports/remicade-biosimilar-market

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com

Future Market Insights is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Newark, with a global delivery center in Pune and offices in the United Kingdom and United Arab Emirates, FMI delivers actionable insights across industries including food & beverage, healthcare, chemicals, and consumer goods.

An ESOMAR-certified organization, FMI provides data-driven insights to support strategic decision-making for global businesses.

This release was published on openPR.